Antiplatelet therapy in the management of cardiovascular disease in patients with CKD: what is the evidence?

Item

http://www.wikidata.org/entity/Q38048245

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Antiplatelet therapy in the ma ...... ith CKD: what is the evidence?

@en

type

Item

label

Antiplatelet therapy in the ma ...... ith CKD: what is the evidence?

@en

prefLabel

Antiplatelet therapy in the ma ...... ith CKD: what is the evidence?

@en

P1476

Antiplatelet therapy in the ma ...... ith CKD: what is the evidence?

@en

P2093

Nishank Jain

http://www.w3.org/2001/XMLSchema#string

Ravindra Sarode

http://www.w3.org/2001/XMLSchema#string

Robert F Reilly

http://www.w3.org/2001/XMLSchema#string

S Susan Hedayati

http://www.w3.org/2001/XMLSchema#string

Subhash Banerjee

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin for the Primary Prevention of Cardiovascular Events: An Update of the Evidence for the U.S. Preventive Services Task Force

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Sex differences in platelet reactivity and response to low-dose aspirin therapy

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis

Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease

Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry

The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study

P304

665-674

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.06790712

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23024160

http://www.w3.org/2001/XMLSchema#string

P932

5972379

http://www.w3.org/2001/XMLSchema#string